Therapeutic Classification: agents for atypical mycobacterium, anti-infectives, antiulcer agents
Pharmacologic Classification: macrolides
REMS
Spectrum:
Absorption: Rapidly absorbed (50%) after oral administration.
Distribution: Widely distributed; tissue levels may exceed those in serum.
Protein Binding: 6570%.
Half-Life: Dose-dependent and prolonged with renal dysfunction 250-mg dose: 34 hr; 500-mg dose: 57 hr.
Contraindicated in:
Use Cautiously in:
CV: QT interval prolongation, TORSADES DE POINTES
Derm: ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS, DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS), pruritus, rash, STEVENS-JOHNSON SYNDROME, TOXIC EPIDERMAL NECROLYSIS
GI: CLOSTRIDIOIDES DIFFICILE-ASSOCIATED DIARRHEA (CDAD), abdominal pain/discomfort, abnormal taste, diarrhea, dyspepsia, HEPATOTOXICITY, nausea
Neuro: headache
Misc: HYPERSENSITIVITY REACTIONS (INCLUDING ANAPHYLAXIS AND ANGIOEDEMA)
Drug-drug:
Renal Impairment
Lab Test Considerations:
NDC Code